Patents by Inventor Tracy Gentry

Tracy Gentry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stem cell populations and methods of use
    Patent number: 8986744
    Abstract: The present invention relates to populations of stem cells, methods for isolating these stem cell populations, and methods repairing, regenerating, and reconstituting tissues using the these stem cell populations. The invention additionally relates to methods of screening agents that promote growth, engraftment, or differentiation of stem cells.
    Type: Grant
    Filed: December 13, 2010
    Date of Patent: March 24, 2015
    Assignee: Aldagen, Inc.
    Inventors: Tracy Gentry, Sandra J. Foster, Andrew E. Balber
  • Treating amyotrophic lateral sclerosis (ALS)with isolated aldehyde dehydrogenase-positive umbilical cord blood cells
    Patent number: 8765119
    Abstract: A method of treating a patient with a neurodegenerative disease, such as ALS, using progenitor cells isolated from human umbilical cord blood. Non-invasive transplantation of aldehyde dehydrogenase (ALDH+) expressing progenitor cells provides cell replacement and protection of motor neurons.
    Type: Grant
    Filed: May 6, 2005
    Date of Patent: July 1, 2014
    Assignees: University of South Florida, Saneron CCEL Therapeutics, Inc., StemCo Biomedical, Inc.
    Inventors: Svitlana Garbuzova-Davis, Andrew Balber, Cyndy Davis-Sanberg, Tracy Gentry, Nicole Kuzmin-Nichols, Paul R Sanberg, Alison Willing
  • STEM CELL POPULATIONS AND METHODS OF USE
    Publication number: 20110189211
    Abstract: The present invention relates to populations of stem cells, methods for isolating these stem cell populations, and methods repairing, regenerating, and reconstituting tissues using the these stem cell populations. The invention additionally relates to methods of screening agents that promote growth, engraftment, or differentiation of stem cells.
    Type: Application
    Filed: December 13, 2010
    Publication date: August 4, 2011
    Applicant: Aldagen, Inc.
    Inventors: Tracy Gentry, Sandra J. Foster, Andrew E. Balber
  • Stem cell populations and methods of use
    Patent number: 7863043
    Abstract: Populations of stem cells and methods for their isolation and use are provided. These stem cell populations comprise aldehyde dehydrogenase positive (ALDHbr) cells isolated from bone marrow, and ALDHbr CD105+ cells derived from any stem cell source. These populations may also comprise cells expressing such surface markers as CD34, CD38, CD41, CD45, CD105, CD133, CD135, CD117, and HLA-DR, and/or are substantially free from such cell surface markers as CD3, CD7, CD 10, CD 13, CD 14, C1319, CD33, CD35, CD56, CD 127, CD 138, and glycophorin A. The population may also comprise cells expressing CD90. The stem cell populations of the invention are isolated from a stem cell source such as bone marrow, peripheral blood, umbilical cord blood, and fetal liver. Methods of the invention comprise isolating and purifying stem cell populations from stem cell sources, and methods of using these cells to reconstitute, repair, and regenerate tissues.
    Type: Grant
    Filed: May 4, 2004
    Date of Patent: January 4, 2011
    Assignee: Aldagen, Inc.
    Inventors: Tracy Gentry, Sandra J. Foster, Andrew E. Balber
  • Stem Cell Populations and Methods of Use
    Publication number: 20080241171
    Abstract: Populations of stem cells and methods for their isolation and use are provided. These stem cell populations comprise aldehyde dehydrogenase positive (ALDHbr) cells isolated from bone marrow, and ALDHbr CD105+ cells derived from any stem cell source. These populations may also comprise cells expressing such surface markers as CD34, CD38, CD41, CD45, CD105, CD133, CD135, CD117, and HLA-DR, and/or are substantially free from such cell surface markers as CD3, CD7, CD 10, CD 13, CD 14, C1319, CD33, CD35, CD56, CD 127, CD 138, and glycophorin A. The population may also comprise cells expressing CD90. The stem cell populations of the invention are isolated from a stem cell source such as bone marrow, peripheral blood, umbilical cord blood, and fetal liver. Methods of the invention comprise isolating and purifying stem cell populations from stem cell sources, and methods of using these cells to reconstitute, repair, and regenerate tissues.
    Type: Application
    Filed: May 4, 2004
    Publication date: October 2, 2008
    Applicant: Aldagen , Inc.
    Inventors: Tracy Gentry, Sandra J. Foster, Andrew E. Balber
  • Cerebral Intraventricular Transplantation as Method of Treating Amyotrophic Lateral Sclerosis (ALS)
    Publication number: 20050249708
    Abstract: A method of treating a patient with a neurodegenerative disease, such as ALS, using progenitor cells isolated from human umbilical cord blood. Non-invasive transplantation of aldehyde dehydrogenase (ALDH+) expressing progenitor cells provides cell replacement and protection of motor neurons.
    Type: Application
    Filed: May 6, 2005
    Publication date: November 10, 2005
    Applicant: UNIVERSITY OF SOUTH FLORIDA
    Inventors: Svitlana Garbuzova-Davis, Andrew Balber, Cyndy Davis-Sanberg, Tracy Gentry, Nicole Kuzmin-Nichols, Paul Sanberg, Alison Willing